GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
45 hedge funds and large institutions have $57.4M invested in Genocea Biosciences, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
10% more funds holding
Funds holding: 41 → 45 (+4)
Holders
45
Holding in Top 10
2
Calls
$6.02M
Puts
$362K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$4.4M | |
| 3 | +$2.61M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.29M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.94M |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$1.18M | |
| 3 | -$345K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$48K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$35.5K |